Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies.
Schellong G, Riepenhausen M, Bruch C, Kotthoff S, Vogt J, Bölling T, Dieckmann K, Pötter R, Heinecke A, Brämswig J, Dörffel W. Schellong G, et al. Among authors: riepenhausen m. Pediatr Blood Cancer. 2010 Dec 1;55(6):1145-52. doi: 10.1002/pbc.22664. Pediatr Blood Cancer. 2010. PMID: 20734400
High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.
Schellong G, Pötter R, Brämswig J, Wagner W, Prott FJ, Dörffel W, Körholz D, Mann G, Rath B, Reiter A, Weissbach G, Riepenhausen M, Thiemann M, Schwarze EW. Schellong G, et al. Among authors: riepenhausen m. J Clin Oncol. 1999 Dec;17(12):3736-44. doi: 10.1200/JCO.1999.17.12.3736. J Clin Oncol. 1999. PMID: 10577845 Clinical Trial.
Quality of life in long-term survivors following treatment for Hodgkin's disease during childhood and adolescence in the German multicentre studies between 1978 and 2002.
Calaminus G, Dörffel W, Baust K, Teske C, Riepenhausen M, Brämswig J, Flechtner HH, Singer S, Hinz A, Schellong G. Calaminus G, et al. Among authors: riepenhausen m. Support Care Cancer. 2014 Jun;22(6):1519-29. doi: 10.1007/s00520-013-2114-y. Epub 2014 Jan 12. Support Care Cancer. 2014. PMID: 24415000
[Reducing radiation dosage to 20-30 Gy in combined chemo-/radiotherapy of Hodgkin's disease in childhood. A report of the cooperative DAL-HD-87 therapy study].
Schellong G, Hörnig-Franz I, Rath B, Ritter J, Riepenhausen M, Kabisch H, Goldschmitt-Wuttge B, Schmidt P, Niethammer D, Gaedicke G, et al. Schellong G, et al. Among authors: riepenhausen m. Klin Padiatr. 1994 Jul-Aug;206(4):253-62. doi: 10.1055/s-2008-1046611. Klin Padiatr. 1994. PMID: 7967421 Clinical Trial. German.
Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence--an observational study with up to 33-year follow-up.
Schellong G, Riepenhausen M, Ehlert K, Brämswig J, Dörffel W; German Working Group on the Long-Term Sequelae of Hodgkin's Disease; Schmutzler RK, Rhiem K, Bick U; German Consortium for Hereditary Breast and Ovarian Cancer. Schellong G, et al. Among authors: riepenhausen m. Dtsch Arztebl Int. 2014 Jan 6;111(1-2):3-9. doi: 10.3238/arztebl.2014.0003. Dtsch Arztebl Int. 2014. PMID: 24565270 Free PMC article.
15 results